Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06261554
NA

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Sponsor: Medical University of Warsaw

View on ClinicalTrials.gov

Summary

It is a randomized, single-center, controlled trial to evaluate the effectiveness of oral immunotherapy with low-dose sesame protein compared with standard treatment (elimination diet) in patients with sesame allergy.

Official title: Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

3 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

39

Start Date

2024-03-14

Completion Date

2027-03-01

Last Updated

2024-05-20

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

Dietary Supplement: Low dose OIT

Following the building-up phase (up to 14 months), patients will receive a daily low dose of sesame paste (300 mg sesame protein) mixed with well-tolerated fruit mousse or bread for 3 months (12 +/- 3 weeks).

Locations (1)

Medical University of Warsaw

Warsaw, Masovian Voivodeship, Poland